Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Fugère

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|June 1, 2005
Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibitionMartin Fugère, Robert Day
Current Pharmaceutical Design|April 12, 2002
Inhibitors of the subtilase-like pro-protein convertases (SPCs)Martin Fugère, Robert Day
Journal of Virology|February 14, 2003
Furin processing and proteolytic activation of Semliki Forest virusXinyong Zhang, Martin Fugère, Robert Day, et al.
FEBS Letters|July 24, 2002
Processing of proendothelin-1 by members of the subtilisin-like pro-protein convertase familyVéronique Blais, Martin Fugère, Jean-Bernard Denault, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2003
Optimization of protease-inhibitor interactions by randomizing adventitious contactsTomoko Komiyama, Bryan VanderLugt, Martin Fugère, et al.
FEBS Letters|November 19, 2003
TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activityNadim Srour, Annie Lebel, Stephanie McMahon, et al.
The Journal of Biological Chemistry|November 28, 2001
Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomainsMartin Fugère, Polizois C Limperis, Véronique Beaulieu-Audy, et al.
Journal of Medicinal Chemistry|November 7, 2012
The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cellsChristine Levesque, Martin Fugère, Anna Kwiatkowska, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|June 1, 2005
Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibitionMartin Fugère, Robert Day
Current Pharmaceutical Design|April 12, 2002
Inhibitors of the subtilase-like pro-protein convertases (SPCs)Martin Fugère, Robert Day
Journal of Virology|February 14, 2003
Furin processing and proteolytic activation of Semliki Forest virusXinyong Zhang, Martin Fugère, Robert Day, et al.
FEBS Letters|July 24, 2002
Processing of proendothelin-1 by members of the subtilisin-like pro-protein convertase familyVéronique Blais, Martin Fugère, Jean-Bernard Denault, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2003
Optimization of protease-inhibitor interactions by randomizing adventitious contactsTomoko Komiyama, Bryan VanderLugt, Martin Fugère, et al.
FEBS Letters|November 19, 2003
TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activityNadim Srour, Annie Lebel, Stephanie McMahon, et al.
The Journal of Biological Chemistry|November 28, 2001
Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomainsMartin Fugère, Polizois C Limperis, Véronique Beaulieu-Audy, et al.
Journal of Medicinal Chemistry|November 7, 2012
The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cellsChristine Levesque, Martin Fugère, Anna Kwiatkowska, et al.
Pageof 1